SpaceX Supplier Applied Aerospace Debuts on Wall Street, Analysts Set Buy Ratings and Price Targets Up to $24

A New Defense IPO Gets the Wall Street Treatment

Applied Aerospace & Defense — ticker AADX — raised $650 million in its initial public offering, pricing shares at $20 each. The company was created through a merger of Applied Aerospace Structures and PCX Aerosystems, according to CNBC. Shares closed last Friday at $20.53, up roughly 2% from the IPO price.

The company's business is defense-focused: it supplies critical subsystems for rotary and fixed-wing tactical aircraft, missiles, munitions, radars, and space launch vehicles. One notable customer is SpaceX. AADX supports SpaceX's reusable landing systems.

Bank of America Securities and RBC Capital Markets served as book-running managers for the offering. Baird, Stifel, and Wolfe/Nomura Alliance were also book runners.

What Analysts Are Saying

Following the standard post-IPO blackout period, analysts at multiple major banks initiated coverage on Monday.

Wolfe Research analyst Myles Walton assigned an outperform rating with a $23 price target, implying about 12% upside from Friday's close. Walton described AADX as filling "the niche of a mid-tier 100% defense-focused supplier with deep material science expertise and broad customer exposure." He forecast mid-teen organic sales growth and 20% EBITDA growth over the next few years.

Bank of America went a step further, issuing a buy rating and a $24 price target — roughly 17% above Friday's close. The bank forecast 14% revenue CAGR from 2025 through 2030, along with approximately 350 basis points of margin expansion by 2030, citing multiple growth vectors and operating leverage.

Wolfe's Walton also noted that AADX's current margins are "solidly 20%+" and that the company's process intellectual property and intentional avoidance of commercial aerospace exposure — 0% commercial aero by design — should enable modest further margin expansion.

The SpaceX Angle

SpaceX itself is not accessible to most retail investors in the traditional sense, so suppliers like Applied Aerospace offer a way into the space launch trade without buying SpaceX directly.

SpaceX shares have had a volatile stretch. According to CNBC, they pulled back 35% from their recent high before staging a recovery. On the session covered in the sources, SpaceX shares rallied 7% to the highest level since the prior Tuesday, driven by speculation that SpaceX could acquire a mobile carrier and by a deal between Rocket Lab and Iridium Communications that renewed attention on satellite communications.

Options activity in SpaceX has been heavily bullish. Traders bought more than four times as many calls as puts, with total call volume double that of puts, according to ThinkOrSwim data cited by CNBC. Of the top 10 contracts by volume, seven were calls and nine were set to expire Thursday.

Charles Moon, a tech and momentum specialist at Prosper Trading Academy in Chicago, told CNBC that SpaceX "defended its all-time low around $147, which tells me there's buyer demand on the pullback." Moon said he bought SpaceX stock alongside 170-strike calls.

One notable institutional trade: when SpaceX was at $155, a trader sold roughly $450,000 worth of 150-strike puts expiring January 2027 and simultaneously bought the same number of 160-strike calls, a structured bullish position.

Rocket Lab also saw outsized movement, gaining 16% in the session, with options volume running 50% above the 30-day average. Calls outpaced puts by a four-to-one ratio, according to CNBC.

The Skeptical Case

The bullish setup deserves scrutiny. AADX is trading only marginally above its IPO price, and the analyst targets were set by firms that also served as book runners on the offering. That's a standard arrangement on Wall Street, but it means the analysts initiating with buy ratings have a financial relationship with the company they are covering. Readers should weigh those targets accordingly.

On the SpaceX side, the 300-strike call contracts expiring Thursday — the second-most popular by volume on that session — represent bets that SpaceX would nearly double in a matter of days. Moon was blunt about those trades: "The 300-strike buyers are trying to force a gamma squeeze with those trades but market-makers know better at this point and that's unlikely to happen." Speculative froth in options markets does not confirm the underlying investment thesis.

Defense supplier stocks also carry their own risk profile. Revenue growth projections spanning to 2030 assume stable Pentagon budgets, continued SpaceX launch cadence, and no supply chain disruptions. None of these are guaranteed.

What to Watch

Bank of America's 14% revenue CAGR forecast runs through 2030, meaning it will take years to validate or disprove. The more immediate question is whether AADX can hold above its $20 IPO price once the initial analyst coverage momentum fades. The stock has barely moved since its debut, and the next real test will come when the company reports its first quarterly earnings as a public company.